Protein Synthesis Inhibitors Flashcards

1
Q

From which be bacterial species do we obtain aminoglycosides?

A

Streptomyses 1943

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What biochemically active structure to the aminoglycosides drugs contain ?

And what does it consist of?

A

Linked ring system , amigos sugars and polyalcohols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How should aminoglycosides be administered to the body?

What bacteria does this drug target ?

A

Poor oral absorption (give IV),

potent broad spectrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of aminoglycosides?

A

(Mycin) strepto, kana, tobra, neo, genta and amikacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What organism do aminoglycosides have good coverage?

A

Gram negative bacilli and staphylococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What organisms do aminoglycosides have poor coverage?

A

Anaerobes and streptococci

NB. However active with penicillin (synergists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How well are aminoglycosides absorbed into tissues etc.?

How does this reflect on its administration/clinical use?

A

Poor mammalian cell penetration!
, hence … Not got for intracellular organism

-instead septicaemia and endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dangers/ Sid effect of aminoglycosides ?

A

Ototoxic & nephrotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aminoglycosides- mode of action

1) this molecule binds to ribosome and does what?

A

Non functioning initiating complexes, Inhibits translocation step of protein synthesis causing misreads of mRNA transcript - causing defective proteins

(Does not fully explain potent bacteriocidal properties)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aminoglycosides- cell penetration and entry

A
  • enter cell via active transport, self regulated uptake via dysfunction proteins disorganising membrane further.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aminoglycosides - resistance mechanism (x2)

A

Alteration of ribosome structure (target change)

Aminoglycosidic modifying enzyme (enzymatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Remember drugs via ; “CLEan TAG” …. explain?

A

Oral, Chloramphenicol and Clindomycin
Oral, Lincosamides
Oral, Erythromycin

IV, Tetracycline and tigicylcine
IV, AminoGlycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What species are tetracyclines derived from?

A

Streptomyces aurofaciens 1948

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What organisms do tetracycline have good coverage of?

A

V. Broad spectrum drugs
Gram -ive and +ive rickettsia,chylamidia, mycoplasma and spirochetes
(NB similar activity, but Pharmokinetically different)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which drugs come under “natural tetracyclines “

A

Chlortetracycline
Tetracycline
Oxytetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which drugs come under semi-synthetic ?

A

Doxycycline

Minocycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the clinical implications of semi-synthetic tetracyclines

A

Once/twice daily (long H.F)
lower renal toxicity
Better than other when taken orally!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tetracyclines - penetration and action

So when susceptible bacteria are exposed to gees drugs what happens?

A

Bacteria concentrate tetracyclines via active transport (bacteria static)
interact with 30 subunit (TAG)
Interfere with tRNA binding to A site on ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does resistance to tetracyclines occur normally?

A

Via production of new proteins that prevent accumulation in cohort with effluent mechanism, purveying resistance to all of here drugs

NB, ECEPT tigecycline avoids this due extreme affinity for ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

From which organism is chloramphenicol derived

A

Streptomyces 1940’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chloramphenicol, what are the pro’s of this drug.?

A

Broad spectrum agent

Simple organisation - easy to synthesise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

For which organisms does this drug have good coverage ?

How? Briefly …

A

Broad spectrum
G-Ive and G+ive, rickettsia chylamidia

Target 70s ribosome, thus largely bactiostatic but is bacteriocidal to some.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chloramphenicol - clinical implications

A

Defuses well into CSF.

Thus, used for meningitis and typhoid (intracellular)

24
Q

How does resistance occur to chloramphenicol ?

A

Normally enzymatic, acylating two OH groups

However uncommon. Problem in Dev. World

25
Q

what are the side effects of chloramphenicol

A

aplastic anaemia.
used for life threatening infections only.
or
when sae therapies failed/infection is resistant

26
Q

neonatal side effects on chloramphenicol ?

A

liver incapable of detoxification enough drug, sufficient to kill bacteria, leads to – hypotention, c.v collapse, grey baby syndrome(fatal)

27
Q

chloramphenicol applications and implications on bone marrow side effects.

A

Dose related BM suppression (4g/m a day- reversible).
Total BM depression & aplastic anaemia rare! (mortality. >50%).
Now used topically, rarely used systemically
Cheap (dev. world & typhoid fever/ meningitis

28
Q

From what organism is “Fusic Acid” derived?

A

Fusidium 1960’s

29
Q

Molecularly how does Fusic acid inhibit protein synthesis?

A

Prevents translocation step in protein synthesis via inhibition of “elongation factor G” recycling.

30
Q

what organism does Fusic acid have good coverage

A

in vitro active against gram positive & negative, however G-ive prevent acess through membrane.
clinically used for staph. inf. only!

31
Q

any good clinical feature of Fusic acid as atibiotic?

A

good bone and tissue penetration - osteomyelitis.

32
Q

Resistance to Fusic acid? if so how (we think)?

A

resistance variants in any population, single point mutation renders resistance, proliferative with therapy ADD another antibiotic!

33
Q

side effects of Fusic acid ?

oral?
IV
topical?

A

no problem,
reversible jaundice
non, but resistance risk!

34
Q

From which organism is a macrolide derived?

A

streptomyces erythrens

35
Q

Macrolides, how do they work?

A

cause dissociation of growing peptide chain from ribosome during translocation

36
Q

antibiotic coverage of macrolides?

A

usually used for staphylococcal and streptococcal inf., but als legionella chlamydia and mycoplasma.
(good cellular penetration for intracellular)

37
Q

side effects and resistance issues, of Fusic acid?.

A

nausea and abdominal cramps.

resistance = modification of 50s rRNA or enzyme inactivation.

38
Q

Macrolides how are they given and absorbed?

A

erythromycin, enteric coat ->SoA small intestine.
Azithromycin, semi synthetic , long HL in blood & tissues.
Clarithromycin, better absorbed, fewer side effects.

39
Q

from which organism does mupirocin derive?

A

pseudomonas flourescens

40
Q

How does Mupirocin function as antibiotic?

A

blocks incorporation of amino acid into poplypeptides.

41
Q

What organisms does mupirocin have good coverage?

A

staphylococi and streptococci sp.

42
Q

clinical applications of mupirocin?

A

inactivated when used topically
sometimes used for nasal carriage of staph. MRSA!
in particular..

43
Q

streptogramins originate from which organism

A

streptomyces sp.

44
Q

streptogramins, in organisation and funtion. what are they?

A

cyclic peptides administered in combination with/from two groups A + B, alone feeble, together potent.

45
Q

within combination streptogramin antibiotic regimes ,

quinopristin?

dalfopristin?

A

premature release of peptide chain
&
prevents peptide elongation

46
Q

streptogramins, organism coverage?

A

use for Vanc. resistant enterococci (VRE) E. faceium only!, no activity against other similar sp.

47
Q

Lincosamides derive from which organism?

A

Streptomyces lincolnensis

48
Q

lincosamides, how does is work?,

A

interfere with peptide elongation, exact mechanism unsure ??

49
Q

Lincosamides, good coverage for which organisms?

A

Treat Gram positive cocci and anaerobes
• No action against the Gram negative bacilli
• Associated with Clostridium difficile infections

(clindamycin)

50
Q

oxazolidinones 1978, is a narrow spectrum dug for mainly which organisms?

A

staphylococci, pneumonococci & enterococci

51
Q

Oxazolidinones, how are they taken and how do they work?

A

orally well absorbed.

target 23s ribosomal RNA in he 50s subunit - this prevents formation of a functional 70 complex.

52
Q

oxazolidinones, resistance occurrence?

linezolid

A

resistance is slow to occur, (mutation in 23s RNA).
no cross resistance with other drugs.
reserved for resistant organisms - VRE, MRSA & TB

53
Q

oxazolidinones - side effects?

A

limited use - effect on bone marrow cells, limits use to a fortnight.

54
Q

oxazolidinones -most recently a cross resistance has occured with chloramphenicol mutation CFr… how is this resisting these drugs?

A

resistance occurs within RNA methyl transferase - enzyme modifying target.
Also gives resistance to streptogrammins, lincosamiddes, chloramphenicol and pleuromutlins (topical antibiotic MRSA).
this transferable plasmid adds CH3 to RNA (in particular 23s RNA)

55
Q

Orthomycins, what are they how do they work?

A

Oligosaccharide based.

Blocks tRNA attachment to 30s ribosomal subunit.

56
Q

orthomycins - narrow spectrum for which organisms?

A

staph, strep, entero an clostridium
possible interest for resistant organisms
however has been used as growth promotorin animals (avilamycin), so a similar resistance may already be here!

57
Q

What key targets do protein synthesis inhibitors work on to produce such bacteriocidal/static effects ?

A

The drugs work via exploiting 70s (50 &30) ribosomal subunits.

Specifically structural differences and affinity towards prokaryote ribosomes

(NB. Tetracyclines also effect eukaryotic - Protozoa)